UY28148A1 - Bromhidrato de escitalopram y un metodo para su preparacion - Google Patents

Bromhidrato de escitalopram y un metodo para su preparacion

Info

Publication number
UY28148A1
UY28148A1 UY28148A UY28148A UY28148A1 UY 28148 A1 UY28148 A1 UY 28148A1 UY 28148 A UY28148 A UY 28148A UY 28148 A UY28148 A UY 28148A UY 28148 A1 UY28148 A1 UY 28148A1
Authority
UY
Uruguay
Prior art keywords
preparation
scitalopram
bromhydrate
escitalopram
citalopram
Prior art date
Application number
UY28148A
Other languages
English (en)
Spanish (es)
Inventor
Hans Petersen
Robert Dancer
Peter Ellegaard
Lawrence Martel
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32668635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28148(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of UY28148A1 publication Critical patent/UY28148A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
UY28148A 2002-12-23 2003-12-23 Bromhidrato de escitalopram y un metodo para su preparacion UY28148A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200202005 2002-12-23

Publications (1)

Publication Number Publication Date
UY28148A1 true UY28148A1 (es) 2004-09-30

Family

ID=32668635

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28148A UY28148A1 (es) 2002-12-23 2003-12-23 Bromhidrato de escitalopram y un metodo para su preparacion

Country Status (32)

Country Link
US (1) US20040167209A1 (https=)
EP (1) EP1578738B1 (https=)
JP (2) JP4658613B2 (https=)
KR (1) KR20050086933A (https=)
CN (1) CN100349885C (https=)
AR (1) AR042652A1 (https=)
AT (1) ATE388947T1 (https=)
AU (1) AU2003287919B2 (https=)
BR (1) BR0317623A (https=)
CA (1) CA2511142A1 (https=)
CY (1) CY1107451T1 (https=)
DE (1) DE60319739T2 (https=)
DK (1) DK1578738T3 (https=)
EA (1) EA013116B1 (https=)
EG (1) EG24729A (https=)
ES (1) ES2298595T3 (https=)
IL (1) IL169125A0 (https=)
IS (1) IS2654B (https=)
ME (1) MEP5808A (https=)
MX (1) MXPA05005772A (https=)
MY (1) MY135468A (https=)
NO (1) NO20053595L (https=)
NZ (1) NZ540281A (https=)
PE (1) PE20040924A1 (https=)
PL (1) PL378275A1 (https=)
PT (1) PT1578738E (https=)
RS (1) RS51092B (https=)
TW (1) TW200501943A (https=)
UA (1) UA80170C2 (https=)
UY (1) UY28148A1 (https=)
WO (1) WO2004056791A1 (https=)
ZA (1) ZA200504109B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80170C2 (en) * 2002-12-23 2007-08-27 Lundbeck & Co As H Escitalopram hydrobromide
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
AU2005218713B2 (en) * 2004-03-05 2009-11-19 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
AU2006304889A1 (en) * 2005-10-14 2007-04-26 H. Lundbeck A/S Stable pharmaceutical formulations containing escitalopram and bupropion
EP1954257A4 (en) * 2005-10-14 2009-05-20 Lundbeck & Co As H METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
ES2687756T3 (es) * 2006-07-11 2018-10-29 Mitsubishi Tanabe Pharma Corporation Sal de un compuesto de morfolina
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FR3006594A1 (fr) * 2013-06-11 2014-12-12 Sorin Crm Sas Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) * 2017-06-05 2022-12-06 上海奥博生物医药股份有限公司 一种艾司西酞普兰双羟萘酸盐新的制备方法
RU2020111694A (ru) * 2017-10-09 2021-11-12 Тева Фармасьютикал Индастриз Лтд. Новые соли и твердые формы эсциталопрама
US20240100012A1 (en) 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34712A (en) * 1862-03-18 James h
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
CA2291134C (en) * 1998-10-20 2006-05-23 H. Lundbeck A/S Method for the preparation of citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
TR200401456T1 (tr) * 1999-10-25 2005-04-21 H. Lundbeck A/S Sitalopram hazırlanması için yöntem.
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
JP2002020379A (ja) * 2000-05-02 2002-01-23 Sumika Fine Chemicals Co Ltd シタロプラム臭化水素酸塩の結晶およびその結晶化方法
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
BR0115907B1 (pt) * 2000-12-04 2011-10-04 processo para o tratamento prévio de óleos crus e graxas cruas para uma subsequente transesterificação alcalina com álcoois primários e/ou secundários e processo para a produção de ésteres de ácido graxo de álcoois primários e/ou secundários a partir de óleos crus ou graxas cruas que contém ácidos graxos livres e substáncias mucilaginosas ou a partir de óleos velhos carregados com ácidos graxos livres da indústria alimentìcia.
EA200301195A1 (ru) * 2001-05-01 2004-04-29 Х. Лундбекк А/С Применение энантиомерно чистого эсциталопрама
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
UA80170C2 (en) * 2002-12-23 2007-08-27 Lundbeck & Co As H Escitalopram hydrobromide
US20050174782A1 (en) * 2003-03-25 2005-08-11 Chapman Leonard T. Flashlight

Also Published As

Publication number Publication date
CA2511142A1 (en) 2004-07-08
EA200501046A1 (ru) 2005-12-29
US20040167209A1 (en) 2004-08-26
DE60319739T2 (de) 2008-07-17
TW200501943A (en) 2005-01-16
JP2011037893A (ja) 2011-02-24
CN100349885C (zh) 2007-11-21
MEP5808A (xx) 2010-02-10
NZ540281A (en) 2008-07-31
JP2006514952A (ja) 2006-05-18
CY1107451T1 (el) 2012-12-19
DE60319739D1 (de) 2008-04-24
PL378275A1 (pl) 2006-03-20
DK1578738T3 (da) 2008-06-30
IL169125A0 (en) 2009-02-11
MY135468A (en) 2008-04-30
PT1578738E (pt) 2008-04-11
RS20050487A (sr) 2007-06-04
EA013116B1 (ru) 2010-02-26
EP1578738A1 (en) 2005-09-28
HK1087708A1 (en) 2006-10-20
PE20040924A1 (es) 2004-12-11
RS51092B (sr) 2010-10-31
IS2654B (is) 2010-08-15
BR0317623A (pt) 2005-11-29
AU2003287919B2 (en) 2009-11-12
EG24729A (en) 2010-06-21
KR20050086933A (ko) 2005-08-30
ZA200504109B (en) 2006-08-30
CN1726202A (zh) 2006-01-25
WO2004056791A1 (en) 2004-07-08
EP1578738B1 (en) 2008-03-12
JP4658613B2 (ja) 2011-03-23
AR042652A1 (es) 2005-06-29
MXPA05005772A (es) 2005-08-16
ATE388947T1 (de) 2008-03-15
NO20053595L (no) 2005-09-05
ES2298595T3 (es) 2008-05-16
UA80170C2 (en) 2007-08-27
IS7848A (is) 2005-05-17
AU2003287919A1 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
CY1107451T1 (el) Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
AR066694A2 (es) Metodo para la preparacion de citalopram
DE602004021120D1 (de) Photopolymerisierbare zusammensetzung.
IT1317757B1 (it) Metodo per la preparazione di idrocarburi idrogenati.
CR7583A (es) Nueva sal formiato de o-desmetil venlafaxina
BR0114221B1 (pt) composição de gesso, processo para fabricação de uma composição de gesso, chapa de gesso e processo para fabricação de chapa de gesso.
MXPA03005222A (es) Derivado de metanosulfonamido-benzofurano, su procedimiento de preparacion y su utilizacion como intermediario de sisntesis.
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
EP1526120A3 (en) Concrete surface retarders
BR9902726B1 (pt) composições estocáveis para cimentação de poços de óleo e gás.
NO20070391L (no) Jernsulfatbasert fosfatadsorbent
BR0204916B1 (pt) mÉtodo para produzir uma olefina.
CO5601045A2 (es) Procedimiento para la fabricacion de compuestos organicos
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
NO20051187L (no) Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon
IS6433A (is) Aðferð til framleiðslu á sítalóprami
BR0101437A (pt) Método para preparar um ciclopropeno
IT1318436B1 (it) Ciclopentadieni sostituiti policiclici e metodo per la loropreparazione.
DK1503803T3 (da) Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps
NL1017717A1 (nl) Gecombineerde plantencoagulaatsamenstelling, werkwijze voor de bereiding ervan en toepassing ervan.
PT1408035E (pt) Metodo de preparacao de derivativos de 1.5-diaril-3-trifluorometilo-delta2-pirazolinas que sejam racemicos e enanciomericamente puros
UY28762A1 (es) Nuevos compuestos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150513